cytidine diphosphate choline has been researched along with Schizophrenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blais, CM; Choueiry, J; Fisher, D; Knott, V; Labelle, A; Shah, D; Smith, D | 1 |
| Aidelbaum, R; Choueiry, J; Knott, V; Labelle, A | 1 |
| Aidelbaum, R; Baddeley, A; Knott, V; Labelle, A | 1 |
| Afarideh, M; Akhondzadeh, S; Ghajar, A; Ghazizadeh-Hashemi, M; Gholamian, F; Rezaei, F; Tabatabei-Motlagh, M | 1 |
| Brown, CH; Deutsch, SI; Rosse, RB; Rosse, SM; Schooler, NR; Schwartz, BL | 1 |
| Deutsch, SI; Gaskins, BL; Long, KD; Mastropaolo, J; Rosse, RB; Schooler, NR; Schwartz, BL | 1 |
5 trial(s) available for cytidine diphosphate choline and Schizophrenia
| Article | Year |
|---|---|
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Cytidine Diphosphate Choline; Galantamine; Humans; Nicotinic Agonists; Nootropic Agents; Pilot Projects; Schizophrenia | 2023 |
The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study.
Topics: Choline; Cytidine Diphosphate Choline; Electroencephalography; Evoked Potentials; Humans; Pilot Projects; Schizophrenia | 2022 |
Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study.
Topics: Adolescent; Adult; Aged; Cytidine Diphosphate Choline; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials; Female; Humans; Male; Middle Aged; Nootropic Agents; Pilot Projects; Schizophrenia; Sensory Gating; Young Adult | 2018 |
Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
Topics: Antipsychotic Agents; Cytidine Diphosphate Choline; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2018 |
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.
Topics: Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Synaptic Transmission; Treatment Outcome | 2013 |
1 other study(ies) available for cytidine diphosphate choline and Schizophrenia
| Article | Year |
|---|---|
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Cytidine Diphosphate Choline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Male; Mice; Nootropic Agents; Schizophrenia | 2008 |